Antiviral agent 25

Modify Date: 2025-08-25 10:17:28

Antiviral agent 25 Structure
Antiviral agent 25 structure
Common Name Antiviral agent 25
CAS Number 2761367-25-1 Molecular Weight 285.34
Density N/A Boiling Point N/A
Molecular Formula C15H12FN3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Antiviral agent 25


Antiviral agent 25 (compound 6g) is a new non-peptide analog covalent inhibitor of SARS-CoV-2 3CLpro. Antiviral agent 25 has a strong inhibitory effect on SARS-CoV-2 3CLpro and SARS-CoV-2 PLpro with IC50 values of 0.118 µM, 0.448 µM, respectively. Antiviral agent 25 has antiviral effect on SARS-CoV-2 with an EC50 value of 7.249 µM[1].

 Names

Name Antiviral agent 25

 Antiviral agent 25 Biological Activity

Description Antiviral agent 25 (compound 6g) is a new non-peptide analog covalent inhibitor of SARS-CoV-2 3CLpro. Antiviral agent 25 has a strong inhibitory effect on SARS-CoV-2 3CLpro and SARS-CoV-2 PLpro with IC50 values of 0.118 µM, 0.448 µM, respectively. Antiviral agent 25 has antiviral effect on SARS-CoV-2 with an EC50 value of 7.249 µM[1].
Related Catalog
Target

SARS-CoV-2 3CLpro:0.118 μM (IC50)

SARS-CoV-2 PLpro:0.448 μM (IC50)

References

[1]. Ren P, et al. Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2. Eur J Med Chem. 2023 Jan 18;249:115129.  

 Chemical & Physical Properties

Molecular Formula C15H12FN3S
Molecular Weight 285.34
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.